Repligen to buy cell therapy maker BioLife in $1.5 billion deal
BioLife SolutionsBioLife Solutions(US:BLFS) Reuters·2026-07-22 18:13

并购交易概述 - Repligen公司宣布将以现金加股票交易方式收购BioLife Solutions公司，交易总价值约为15亿美元 [1] 交易目的与战略意义 - 此次收购旨在扩大该制药设备供应商在快速增长的市场中的业务版图 [1]

BioLife Solutions-Repligen to buy cell therapy maker BioLife in $1.5 billion deal - Reportify